National Cancer Institute (NCI)   Report issue

Founded: Washington DC United States (1937)

Organization Overview

First Clinical Trial
1977
NCT00427570
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2100

Timeline

NOW
  • Now

Alternative names

Accelerared Community Oncology Research Network, Inc. | Accelerated Community Oncology Reseaerch Network, Inc. (ACORN) | Accelerated Community Oncology Research Network | Accelerated Community Oncology Research Network, Inc. | Accelerated Community Oncology Research Network, Inc. (ACORN) | Alliance for Clinical Trials in Oncology | Alliance for Clinical Trials in Oncology Cancer Control Program (CCP) | Children's Oncology Group | Children's Oncology Group (COG) | COG Phase 1 Consortium | COG Phase I Consortium | Lymphoma Trials Office | National Cancer Institute (NCI) | National Cancer Institute/NIH/DHHS (NCI) | New Approaches to Brain Tumor Therapy Consortium | New Approaches to Neuroblastoma Therapy Consortium | New Approaches to Neuroblastoma Therapy Consortium (NANT) | New Approaches to Neuroblastoma Treatment | New Approaches to Neuroblastoma Treatment (NANT) | North American Brain Tumor Consortium | Pediatric Early Phase Clinical Trial Network | Raghu Nandan, M.D., Inc | The Cancer Therapy Evaluation Program of the National Cancer Institute